NCT05830695View on ClinicalTrials.gov

Evaluation of Apexogenesis With Human Treated Dentin Matrix in Young Permanent Molars

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 18, 2022

Primary Completion Date

July 18, 2022

Study Completion Date

March 31, 2023

Conditions
Dentin Bridge
Interventions
DRUG

human treated dentin matrix

human treated dentin matrix is compared with mineral trioxide aggregate in apexogenesis

DRUG

Mineral Trioxide Aggregate

mineral trioxide aggregate was used as control

Trial Locations (1)

31111

Faculty of Dentistry, Tanta University, Tanta

All Listed Sponsors
lead

nora mostafa mohammed abo shanady

OTHER